The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
Controlling timing and location in vaccines
Open accessAbstract
Vaccines are one of the most powerful technologies supporting public health. The adaptive immune response induced by immunization arises following appropriate activation and differentiation of T and B cells in lymph nodes. Among many parameters impacting the resulting immune response, the presence of antigen and inflammatory cues for an appropriate temporal duration within the lymph nodes, and further within appropriate subcompartments of the lymph nodes- the right timing and location- play a critical role in shaping cellular and humoral immunity. Here we review recent advances in our understanding of how vaccine kinetics and biodistribution impact adaptive immunity, and the underlying immunological mechanisms that govern these responses. We discuss emerging approaches to engineer these properties for future vaccines, with a focus on subunit vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–314 of 314
Germinal center enhancement by extended antigen availability
Cirelli, K. M., & Crotty, S. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.06.008 · Cited by 130
Dubrovskaya, V., Tran, K., Ozorowski, G., Guenaga, J., Wilson, R., Bale, S., Cottrell, C. A., Turner, H. L., Seabright, G. E., O'Dell, S. J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.008 · Cited by 130
Detienne, S., Welsby, I., Collignon, C., Wouters, S., Coccia, M., Delhaye, S., Maele, L. V., Thomas, S., Swertvaegher, M., Detavernier, A., et al. (2016) · Scientific Reports · doi:10.1038/srep39475 · Cited by 128
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Marciani, D. J. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.005 · Cited by 127
Shah, N. J., Najibi, A. J., Shih, T., Mao, A. S., Sharda, A., Scadden, D. T., & Mooney, D. J. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0503-3 · Cited by 123
Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization
Wu, Y., Wei, W., Zhou, M., Wang, Y., Wu, J., Ma, G., & Su, Z. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.068 · Cited by 122
Mueller, S. N., Tian, S., & DeSimone, J. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500589c · Cited by 118
Kalams, S. A., Parker, S., Jin, X., Elizaga, M. L., Metch, B. J., Wang, M., Hural, J., Lubeck, M. D., Eldridge, J. H., Cardinali, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029231 · Cited by 115
Dummer, R., Hauschild, A., Becker, J. C., Grob, J., Schadendorf, D., Tebbs, V. M., Skalsky, J., Kaehler, K. C., Moosbauer, S., Clark, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1938 · Cited by 114
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Quinn, K. M., Zak, D. E., Costa, A. D. S., Yamamoto, A., Kastenmüller, K., Hill, B. J., Lynn, G. M., Darrah, P. A., Lindsay, R. W. B., Wang, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78280 · Cited by 113
Shukla, S., Myers, J., Woods, S. E., Gong, X., Czapar, A. E., Commandeur, U., Huang, A. Y.-C., Levine, A. D., & Steinmetz, N. F. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.030 · Cited by 112
Polymeric micro/nanoparticles: Particle design and potential vaccine delivery applications
Yue, H., & Ma, G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.100 · Cited by 109
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
Bershteyn, A., Hanson, M. C., Crespo, M. P., Moon, J. J., Li, A. V., Suh, H., & Irvine, D. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.029 · Cited by 109
Self-citationKinetics of the inflammatory response following intramuscular injection of aluminum adjuvant
Lu, F., & HogenEsch, H. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.107 · Cited by 109
Frey, S. E., Harrison, C., Pass, R. F., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315060 · Cited by 105
Iyer, S., HogenEsch, H., & Hem, S. L. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00556-x · Cited by 104
Jouneau, L., Lefebvre, D. J., Costa, F., Romey, A., Blaise‐Boisseau, S., Relmy, A., Jaszczyszyn, Y., Dard-Dascot, C., Dejean, S., Versillé, N., et al. (2020) · npj Vaccines · doi:10.1038/s41541-019-0151-3 · Cited by 104
Active self-healing encapsulation of vaccine antigens in PLGA microspheres
Desai, K. G. H., & Schwendeman, S. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.012 · Cited by 103
Protein Delivery from Biodegradable Microspheres
Cleland, J. L. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46803-4_1 · Cited by 102
Self‐Healing Microencapsulation of Biomacromolecules without Organic Solvents
Reinhold, S. E., Desai, K. G. H., Zhang, L., Olsen, K. F., & Schwendeman, S. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206387 · Cited by 102
A Self‐Adjuvanting Supramolecular Vaccine Carrying a Folded Protein Antigen
Hudalla, G. A., Modica, J. A., Tian, Y. F., Rudra, J. S., Chong, A. S., Sun, T., Mrksich, M., & Collier, J. H. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200435 · Cited by 102
Bergmann‐Leitner, E. S., & Leitner, W. W. (2014) · Vaccines · doi:10.3390/vaccines2020252 · Cited by 101
Regulation of T cell expansion by antigen presentation dynamics
Mayer, A., Zhang, Y., Perelson, A. S., & Wingreen, N. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812800116 · Cited by 99
Kim, T. W., Lee, J.-H., He, L., Boyd, D. A. K., Hardwick, J. M., Hung, C., & Wu, T.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.309.65.1 · Cited by 98
Maione, D., Rocca, C. D., Giannetti, P., D’Arrigo, R., Liberatoscioli, L., Franlin, L. L., Sandig, V., Ciliberto, G., Monica, N. L., & Savino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101122498 · Cited by 96
Fischer, N. O., Rasley, A., Corzett, M., Hwang, M. H., Hoeprich, P. D., & Blanchette, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3063293 · Cited by 96
Mold, M. J., Shardlow, E., & Exley, C. (2016) · Scientific Reports · doi:10.1038/srep31578 · Cited by 96
Immune Tolerance for Autoimmune Disease and Cell Transplantation
Luo, X., Miller, S. D., & Shea, L. D. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110315-020137 · Cited by 93
Haynes, B. F., & Burton, D. R. (2017) · Science · doi:10.1126/science.aan0662 · Cited by 93
Structural analysis of Fc/FcγR complexes: a blueprint for antibody design
Caaveiro, J. M. M., Kiyoshi, M., & Tsumoto, K. (2015) · Immunological Reviews · doi:10.1111/imr.12365 · Cited by 92
Kashala, O., Amador, R., Valero-Bernal, M. V., Moreno, A., Barbosa, A., Nickel, B., Daubenberger, C., Guzmán, F., Pluschke, G., & Patarroyo, M. E. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00115-9 · Cited by 91
Woodruff, M. C., Heesters, B. A., Herndon, C. N., Groom, J. R., Thomas, P. G., Luster, A. D., Turley, S. J., & Carroll, M. C. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132327 · Cited by 91
Lymph node conduits transport virions for rapid T cell activation
Reynoso, G. V., Weisberg, A. S., Shannon, J. P., McManus, D. T., Shores, L. S., Americo, J. L., Stan, R. V., Yewdell, J. W., & Hickman, H. D. (2019) · Nature Immunology · doi:10.1038/s41590-019-0342-0 · Cited by 90
Noe, S. M., Green, M. A., HogenEsch, H., & Hem, S. L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.085 · Cited by 89
Melo, M., Porter, E., Zhang, Y., Silva, M., Li, N., Dobosh, B., Liguori, A., Skog, P., Landais, E., Menis, S., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.007 · Cited by 88
Self-citationZeng, B., Middelberg, A. P. J., Gemiarto, A. T., MacDonald, K. P. A., Baxter, A. G., Talekar, M., Moi, D., Tullett, K. M., Caminschi, I., Lahoud, M. H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96791 · Cited by 88
Qiu, F. X., Becker, K. W., Knight, F. C., Baljon, J. J., Sevimli, S., Shae, D., Gilchuk, P., Joyce, S., & Wilson, J. T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.052 · Cited by 88
Development of a nanoparticle-based influenza vaccine using the PRINT® technology
Galloway, A. L., Murphy, A., DeSimone, J. M., Di, J., Herrmann, J. P., Hunter, M. E., Kindig, J. P., Malinoski, F. J., Rumley, M. A., Stoltz, D. M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.001 · Cited by 87
Antigen-specific immunotherapies in rheumatic diseases
Pozsgay, J., Szekanecz, Z., & Sármay, G. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.107 · Cited by 86
Monath, T. P. C., Fast, P., Modjarrad, K., Clarke, D. K., Martin, B. K., Fusco, J., Nichols, R., Heppner, D. G., Simon, J. K., Dubey, S. A., et al. (2019) · Vaccine X · doi:10.1016/j.jvacx.2019.100009 · Cited by 85
Moynihan, K. D., Holden, R. L., Mehta, N. K., Wang, C., Karver, M. R., Dinter, J., Liang, S., Abraham, W. D., Melo, M. B., Zhang, A. Q., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0607 · Cited by 83
Self-citationDacoba, T. G., Omange, R. W., Li, H., Crecente‐Campo, J., Luo, M., & Alonso, M. J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07662 · Cited by 83
Tullius, M. V., Harth, G., Masleša-Galić, S., Dillon, B. J., & Horwitz, M. A. (2008) · Infection and Immunity · doi:10.1128/iai.00434-08 · Cited by 82
Rohner, N. A., & Thomas, S. N. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00438 · Cited by 82
Sustained micellar delivery via inducible transitions in nanostructure morphology
Karabin, N. B., Allen, S. D., Kwon, H.-K., Bobbala, S. K. R., Firlar, E., Shokuhfar, T., Shull, K. R., & Scott, E. A. (2018) · Nature Communications · doi:10.1038/s41467-018-03001-9 · Cited by 82
Complement activation by aluminium and zirconium compounds.
Ramanathan, V. D., Badenoch‐Jones, P., & Turk, J. L. (1979) · PubMed · Cited by 80
Harrison, L. I., Astry, C. L., Kumar, S., & Yunis, C. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007303766 · Cited by 80
Kedl, R. M., Lindsay, R. S., Finlon, J. M., Lucas, E. D., Friedman, R. S., & Tamburini, B. A. J. (2017) · Nature Communications · doi:10.1038/s41467-017-02247-z · Cited by 80
Tokatlian, T., Kulp, D. W., Mutafyan, A. A., Jones, C. A., Menis, S., Georgeson, E., Kubitz, M., Zhang, M. H., Melo, M. B., Silva, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34853-2 · Cited by 78
Self-citationTang, J., Zhang, N., Tao, X., Zhao, G., Guo, Y., Tseng, C.-T. K., Jiang, S., Du, L., & Zhou, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1021527 · Cited by 77
Viral and Synthetic RNA Vector Technologies and Applications
Schott, J. W., Morgan, M., Galla, M., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.143 · Cited by 76
Patel, V. V., Jalah, R., Kulkarni, V., Valentin, A., Rosati, M., Alicea, C., von Gegerfelt, A. S., Huang, W., Guan, Y., Keele, B. F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215393110 · Cited by 75
Wilson, N. S., Duewell, P., Yang, B., Li, Y., Marsters, S. A., Koernig, S., Latz, E., Maraskovsky, E., Morelli, A. B., Schnurr, M. M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302011 · Cited by 75
Karch, C. P., Li, J., Kulangara, C., Paulillo, S. M., Raman, S. K., Emadi, S., Tan, A., Helal, Z. H., Fan, Q., Khan, M. I., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.030 · Cited by 73
Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity
Shirota, H., Petrenko, L., Hong, C., & Klinman, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.329 · Cited by 72
Sharpe, S. A., Polyanskaya, N., Dennis, M. J., Sutter, G., Hanke, T., Erfle, V., Hirsch, V. M., & Cranage, M. P. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-9-2215 · Cited by 72
RNA‐Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
Guan, C. M., Chernyak, N., Dominguez, D., Cole, L. E., Zhang, B., & Mirkin, C. A. (2018) · Small · doi:10.1002/smll.201803284 · Cited by 72
Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development
Gonin, P., & Gaillard, C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302378 · Cited by 70
Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines
Mehta, N. K., Pradhan, R., Soleimany, A. P., Moynihan, K. D., Rothschilds, A. M., Momin, N., Rakhra, K., Mata-Fink, J., Bhatia, S. N., Wittrup, K. D., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0563-4 · Cited by 70
Self-citationImmunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination
Guarecuco, R., Lu, J., McHugh, K. J., Norman, J. J., Thapa, L. S., Lydon, E., Langer, R., & Jaklenec, A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.094 · Cited by 69
Lymphatic endothelial cells prime naive CD8+ T cells into memory cells under steady-state conditions
Vokali, E., Yu, S. S., Hirosue, S., Rinçon-Restrepo, M., V. Duraes, F., Scherer, S., Corthésy-Henrioud, P., Kilarski, W. W., Mondino, A., Zehn, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14127-9 · Cited by 69
Li, J., Valentin, A., Kulkarni, V., Rosati, M., Beach, R. K., Alicea, C., Hannaman, D., Reed, S. G., Felber, B. K., & Pavlakis, G. N. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.037 · Cited by 67
Geller, M. A., Cooley, S., Argenta, P. A., Downs, L. S., Carson, L. F., Judson, P. L., Ghebre, R. G., Weigel, B. J., Panoskaltsis‐Mortari, A., Curtsinger, J., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0914-1 · Cited by 67
From therapeutic antibodies to immune complex vaccines
Wang, X., Wang, B., & Wen, Y. (2019) · npj Vaccines · doi:10.1038/s41541-018-0095-z · Cited by 67
Morefield, G. L., Jiang, D., Méndez, I. Z. R., Geahlen, R. L., HogenEsch, H., & Hem, S. L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.048 · Cited by 66
Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
Storni, T., Ruedl, C., Renner, W. A., & Bachmann, M. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.795 · Cited by 65
Cantisani, R., Pezzicoli, A., Cioncada, R., Malzone, C., Gregorio, E. D., D’Oro, U., & Piccioli, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400623 · Cited by 65
Hendrikx, L. H., Berbers, G. A. M., Veenhoven, R. H., Sanders, E. A. M., & Buisman, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.052 · Cited by 65
Johnson, M., Huyn, S., Burton, J., Sato, M., & Wu, L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1262 · Cited by 64
Some Observations on the Use of Alum Precipitated Diphtheria Toxoid
Harrison, W. T. (1935) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.25.3.298 · Cited by 64
Vrieze, J. D., Louage, B., Deswarte, K., Zhong, Z., Coen, R. D., Herck, S. V., Nuhn, L., Frich, C. K., Zelikin, A. N., Lienenklaus, S., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201905687 · Cited by 64
Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response
Tzeng, S. Y., McHugh, K. J., Behrens, A. M., Rose, S., Sugarman, J. L., Ferber, S., Langer, R., & Jaklenec, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720970115 · Cited by 61
de Veer, M., Kemp, J. M., Chatelier, J., Elhay, M. J., & Meeusen, E. N. T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.056 · Cited by 60
Finn, J. D., Bassett, J. D., Millar, J., Grinshtein, N., Yang, T. C., Parsons, R., Evelegh, C. M., Wan, Y., Parks, R. J., & Bramson, J. L. (2009) · Journal of Virology · doi:10.1128/jvi.00593-09 · Cited by 59
Havenar-Daughton, C., Carnathan, D. G., Boopathy, A. V., Upadhyay, A. A., Murrell, B., Reiss, S. M., Enemuo, C. A., Gebru, E. H., Choe, Y., Dhadvai, P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.008 · Cited by 58
Self-citationDolter, K. E., Evans, C. F., Ellefsen, B., Song, J., Boente-Carrera, M., Vittorino, R., Rosenberg, T., Hannaman, D., & Vasan, S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.011 · Cited by 58
Maamary, J., Wang, T. T., Tan, G. S., Palese, P., & Ravetch, J. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707950114 · Cited by 53
Güven, E., Duus, K., Laursen, I., Højrup, P., & Houen, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074445 · Cited by 52
Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review
Andries, O., Kitada, T., Bodner, K., Sanders, N. N., & Weiss, R. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.997714 · Cited by 50
Wick, D. A., Martin, S. D., Nelson, B. H., & Webb, J. R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.036 · Cited by 49
Lundstrom, K. H. (2009) · Viruses · doi:10.3390/v1010013 · Cited by 49
Bigaeva, E., van Doorn, E., Liu, H., & Hak, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154757 · Cited by 49
Sharma, A., Bangari, D. S., Tandon, M., Pandey, A., HogenEsch, H., & Mittal, S. K. (2009) · Virology · doi:10.1016/j.virol.2009.01.008 · Cited by 48
Ross, K. A., Senapati, S., Alley, J., Darling, R. J., Goodman, J., Jefferson, M. A., Uz, M., Guo, B., Yoon, K. J., Verhoeven, D. E., et al. (2019) · Biomaterials Science · doi:10.1039/c8bm01443d · Cited by 48
Germinal center responses to complex antigens
Finney, J., Yeh, C., Kelsoe, G. H., & Kuraoka, M. (2018) · Immunological Reviews · doi:10.1111/imr.12661 · Cited by 46
Catron, D. M., Pape, K. A., Fife, B. T., van Rooijen, N., & Jenkins, M. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000077 · Cited by 45
Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid
Higaki, M., Azechi, Y., Takase, T., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00039-1 · Cited by 43
Schipper, P., van der Maaden, K., Romeijn, S. G., Oomens, C. W. J., Kersten, G. F. A., Jiskoot, W., & Bouwstra, J. A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.055 · Cited by 43
Wei, J., Xue, W., Yu, X., Qiu, X., & Liu, Z. (2017) · Journal of Biomaterials Applications · doi:10.1177/0885328217704139 · Cited by 43
Pepponi, I., Diogo, G. R., Stylianou, E., van Dolleweerd, C. J., Drake, P. M. W., Paul, M. J., Sibley, L. S., K‐C., J., & Reljić, R. (2014) · Plant Biotechnology Journal · doi:10.1111/pbi.12185 · Cited by 42
Lundstrom, K. H. (2015) · Viruses · doi:10.3390/v7052321 · Cited by 41
Griffin, J. F. T., Mackintosh, C. G., & Rodgers, C. R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.033 · Cited by 39
T cell vaccinology: Exploring the known unknowns
Burchill, M. A., Tamburini, B. A. J., Pennock, N. D., White, J. T., Kurche, J. S., & Kedl, R. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.096 · Cited by 38
Stoecklinger, A., Eticha, T. D., Mesdaghi, M., Kissenpfennig, A., MALISSEN, B., Thalhamer, J., & Hammerl, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002557 · Cited by 38
Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission
Kozlowski, P. A., & Aldovini, A. (2018) · Current Immunology Reviews · doi:10.2174/1573395514666180605092054 · Cited by 38
Metz, S., Tian, S., Hoekstra, G., Yi, X., Stone, M., Horvath, K., Miley, M. J., DeSimone, J. M., Luft, C. J., & de Silva, A. M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005071 · Cited by 37
Xu, Z., & Kulp, D. W. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.03.003 · Cited by 37
Ali, O. A., Doherty, E. J., Mooney, D. J., & Emerich, D. F. (2011) · Biomatter · doi:10.4161/biom.1.1.16277 · Cited by 35
Chesson, C. B., Huante, M. B., Nusbaum, R. J., Walker, A. G., Clover, T. M., Jagannath, C., Endsley, J. J., & Rudra, J. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31089-y · Cited by 35
Huyn, S., Burton, J. B., Sato, M., Carey, M., Gambhir, S. S., & Wu, L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2666 · Cited by 34
Wagner, D. A., Kelly, S. M., Petersen, A. C., Peroutka‐Bigus, N., Darling, R. J., Bellaire, B. H., Wannemuehler, M. J., & Narasimhan, B. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.10.016 · Cited by 33
Huang, B., Mao, C.-P., Peng, S., Hung, C., & Wu, T. ‐. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.059 · Cited by 29
McKay, P. F., Hu, K., Blakney, A. K., Samnuan, K., Bouton, C. R., Rogers, P., Polra, K., Lin, P. J. C., Barbosa, C., Tam, Y. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.22.055608 · Cited by 28
Thompson, E. A., Beura, L. K., Nelson, C. E., Anderson, K. G., & Vezys, V. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501797 · Cited by 27
Bioengineering strategies for inducing tolerance in autoimmune diabetes
Bækkeskov, S., Hubbell, J. A., & Phelps, E. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.007 · Cited by 27
Promoters influence the kinetics of transgene expression following adenovector gene delivery
Chen, P., Tian, J., Kovesdi, I., & Bruder, J. T. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1127 · Cited by 26
A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen
Rush, C. M., Mitchell, T. J., & Garside, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.014 · Cited by 20
Khong, H., Volmari, A., Sharma, M., Dai, Z., Imo, C. S., Hailemichael, Y., Singh, M., Moore, D. T., Xiao, Z., Huang, X.-F., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700467 · Cited by 20
Geiben-Lynn, R., Frimpong-Boateng, K., & Letvin, N. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00390-10 · Cited by 13
The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans
Nguyen, D. N. P., Redman, R. L., Horiya, S., Bailey, J. K., Xu, B., Stanfield, R. L., Temme, J. S., LaBranche, C. C., Wang, S., Rodal, A. A., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00053 · Cited by 13
Park, C., & Kehrl, J. H. (2019) · eLife · doi:10.7554/elife.47776 · Cited by 12
A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo
Scales, H. E., Meehan, G. R., Hayes, A. J., Benson, R. A., Watson, E., Walters, A., Tomura, M., Maraskovsky, E., Garside, P., Morelli, A. B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02684 · Cited by 11
Polymeric Particles as Vaccine Delivery Systems
Malyala, P., & O’Hagan, D. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00012-8 · Cited by 8
Cited by
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Translational Applications of Hydrogels
Correa, S., Grosskopf, A. K., Lopez Hernandez, H., Chan, D., Yu, A. C., Stapleton, L. M., & Appel, E. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01177 · Cited by 1,143
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
A Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457
Metadata
- Authors
- Irvine, D. J., Aung, A., & Silva, M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 158
- Pages
- 91-115
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3038037714
- Cited by
- 254
- References
- 314
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.